OPTIMIZATION OF PATIENTS MANAGEMENT IN MYOCARDIAL INFARCTION COMORBIDITY WITH NON-ALCOHOLIC FATTY LIVER DISEASE

QR Code

OPTIMIZATION OF PATIENTS MANAGEMENT IN MYOCARDIAL INFARCTION COMORBIDITY WITH NON-ALCOHOLIC FATTY LIVER DISEASE

Aim. To investigate on the efficacy of thiotriazoline (TTZ) in complex management of acute myocardial infarction (AMI) patients with hepatic steatosis.Material and methods. Totally, 32 left ventricle AMI patients included, comorbid with non-alcoholic fatty liver disease. Assessment of electrical act...

Full description

Saved in:

Bibliographic Details
Main Author:	I. E. Belaya
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2017-12-01
Series:	Российский кардиологический журнал
Subjects:	acute period of myocardial infarction non-alcoholic fatty liver disease vectorcardiography thiotraizoline
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1061
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SENSITIVITY AND SPECIFICITY OF VECTORCARDIOGRAPHY IN DIAGNOSTICS OF ACUTE MYOCARDIAL INFARCTION COMORBID WITH LIVER STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS
by: I. E. Belaya, et al.
Published: (2015-12-01)

MODERN ELECTROCARDIOGRAPHIC METHODS OF ESTIMATION OF CORONARY REPERFUSION AT THROMBOLYSIS IN ACUTE PERIOD OF MYOCARDIAL INFARCTION
by: I. Ye. Belaya
Published: (2014-04-01)

ST-segment elevation myocardial infarction in the presence of metabolic-associated fatty liver disease
by: V. A. Tretyakova, et al.
Published: (2023-12-01)

THE MARKERS OF OXIDATIVE STRESS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH NON-ALCOHOLIC FATTY LIVER DISEASE
by: I. E. Belaya
Published: (2014-07-01)

VECTOR ELECTROCARDIOGRAPHY IN THE DIAGNOSTICS OF FOCAL CHANGES IN THE MYOCARDIUM
by: I. Ye. Belaya, et al.
Published: (2015-04-01)

Improvement of non-alcoholic fatty liver disease treatment
by: P. I. Seliverstov, et al.
Published: (2014-10-01)

Sex-specific effect of dietary fatty acids on non-alcoholic fatty liver disease
by: Jianhua Chen, et al.
Published: (2025-07-01)

Liver Cirrhosis as the Outcome of Non-Alcoholic Fatty Liver Disease Associated with PNPLA3 Gene RS738409 Polymorphism
by: I. G. Nikitin, et al.
Published: (2020-03-01)

Non-alcoholic fatty liver disease and cardiovascular pathology: pathogenetic parallels
by: G. Yu. Knorring, et al.
Published: (2024-08-01)

Draft Clinical Guidelines for the Diagnosis and Treatment of Metabolically Associated Fatty Liver Disease in Children (Non-Alcoholic Fatty Liver Disease)
by: Alexander A. Baranov, et al.
Published: (2025-05-01)

Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion
by: V. V. Tsukanov, et al.
Published: (2023-11-01)

NON-ALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR RISK: SCIENTIFIC PROBLEM STATE
by: O. M. Drapkina, et al.
Published: (2017-11-01)

Epidemiologic features of non-alcoholic fatty liver disease in Russia
by: O. M. Drapkina, et al.
Published: (2014-10-01)

Genetic aspects of non-alcoholic fatty liver disease development
by: V. A. Akhmedov, et al.
Published: (2021-06-01)

NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL
by: D. V. Blinov
Published: (2015-12-01)

The effect of non-alcoholic fatty liver disease on the development of cardiovascular diseases
by: N. A. Starodubtseva, et al.
Published: (2025-03-01)

Intrahepatic Cholestasis in Non-Alcoholic Fatty Liver Disease: Pathogenesis and Role of Ademetionine in Treatment
by: Ye. N. Shirokova
Published: (2023-08-01)

Natural products in the treatment of non-alcoholic fatty liver diseases: A bibliometric analysis
by: He Zhang, et al.
Published: (2025-08-01)

Prevalence of non-alcoholic fatty liver disease among the working-age population: associations with socio-demographic indicators and behavioral risk factors (ESSE RF-2 data)
by: S. E. Evstifeeva, et al.
Published: (2022-10-01)

Metabolic and Genetic Determinants of Lipid Metabolism Disruption in Non-Alcoholic Fatty Liver Disease
by: O. Yu. Kytikova, et al.
Published: (2020-05-01)

Cognitive dysfunction in patients with non-alcoholic fatty liver disease
by: S. A. Smakotina, et al.
Published: (2025-06-01)

Risk of Cirrhosis in Patients with Non-alcoholic Fatty Liver Disease and Previous Viral Hepatitis B
by: S. N. Batskikh, et al.
Published: (2020-09-01)

Metabolic effects of ursodeoxycholic acid in patients with non-alcoholic fatty liver disease
by: V. A. Akhmedov
Published: (2024-04-01)

Liver and Nutrition. An Optimal Diet for Non-Alcoholic Fatty Liver Disease
by: M. V. Mayevskaya, et al.
Published: (2018-11-01)

Methodical approaches in experimental modelling of non-alcoholic fatty liver disease
by: N. V. Bivalkevich, et al.
Published: (2015-09-01)

Food fibers in metabolic syndrome and non-alcoholic fatty liver disease
by: E. V. Onuchina
Published: (2021-06-01)

Pathogenic role of lipids in non-alcoholic fatty liver disease
by: Yu. O. Shulpekova
Published: (2012-02-01)

Assessment of the Functional Status of the Small Intestine in Patients with Non-Alcoholic Fatty Liver Disease
by: Ya. M. Vakhrushev, et al.
Published: (2020-12-01)

Patient Management in Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
by: A. E. Bagriy, et al.
Published: (2021-06-01)

Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy
by: A. V. Nelidova, et al.
Published: (2022-01-01)

Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk
by: O. M. Drapkina, et al.
Published: (2016-09-01)

Acute and sub-chronic toxicity study of novel polyherbal formulation in non-alcoholic fatty liver using Wistar rats
by: Anuragh Singh, et al.
Published: (2024-12-01)

Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors
by: Ignatius Bima Prasetya, et al.
Published: (2017-08-01)

Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors
by: Ignatius Bima Prasetya, et al.
Published: (2017-08-01)

The Interplay of Iron and Lipid Homeostasis in Non-Alcoholic Fatty Liver Disease
by: Clinton J. Kidman, et al.
Published: (2025-03-01)

Non-alcoholic fatty liver disease as a risk factor for anemia of chronic inflammation (experimental research)
by: T. V. Brus, et al.
Published: (2023-07-01)

Association between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis
by: Guntur Darmawan, et al.
Published: (2017-08-01)

Association between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis
by: Guntur Darmawan, et al.
Published: (2017-08-01)

Concerns and recommendations: antiplatelet agents and cancer prevention in non-alcoholic fatty liver disease
by: Hong Tham Pham, et al.
Published: (2025-07-01)

Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular risk factors (data from Russian epidemiological studies)
by: O. M. Drapkina, et al.
Published: (2025-03-01)